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Background: Acute kidney injury (AKI) is a common and a serious complication among patients admitted to intensive
care units (ICUs), and has been the focus of many studies leading to recent advances in diagnosis and classification.
The incidence and outcome of AKI in Sri Lankan ICUs is largely unknown. The aim of this study was to describe the
incidence, severity and outcome of AKI among patients admitted to the medical ICU, National Hospital, Colombo,
Sri Lanka (NHSL).
Methods: Patients admitted to the medical ICU, NHSL, over a period of 6 months were studied prospectively.
Standard demographic, physiological and clinical data were collected. Severity of illness was assessed using SOFA
(Sequential Organ Failure Assessment) score. Diagnosis of AKI was based on Acute Kidney Injury Network (AKIN) criteria.
Results: Of 212 patients screened, 108 satisfied the inclusion criteria; males 67(61.5%); mean age 47.8 years
(SD 19.4, range 12-94). Mean duration of ICU stay was 11.6 days (SD 10.6, range 2-55). Eighty one (75.0%) received
mechanical ventilation. Forty nine (45.4%) had sepsis. ICU mortality was 38.9% and AKI was present in 60.2%. The
majority of AKI patients (38, 58.5%) had AKI stage 3. Patients with AKI were at higher risk of death (p < 0.01). Neither age,
gender, nor the presence of co-morbidities were associated with increased risk of AKI. Patients with AKI had significantly
longer ICU stay (Log-Rank Chi Square: 23.186, p < 0.0001). Both the incidence of AKI and ICU mortality were higher in
patients with SOFA scores over 9 (Pearson Chi-Square 7.581, p = 0.006, and 11.288, p = 0.001 respectively).
Conclusions: The incidence of AKI is high at 60% among our ICU patients, and those with AKI had higher mortality and
longer duration of ICU stay. Age, gender or the presence of co-morbidities was not associated with a higher risk of AKI.
Patients with SOFA scores over 9 within the first 24 hours were more likely to develop AKI and had higher risk of death.
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Acute kidney injury (AKI) is a common and major com-
plication in critical care, and is associated with poor out-
come [1]. The Acute Kidney Injury Network (AKIN)
criteria are currently used to stage acute kidney injury in
practice [2], although RIFLE (Risk, Injury, Failure, Loss
& End-stage kidney disease) criteria [3] have been used
in most large epidemiological studies. Crude mortality
has been shown to be higher with worsening stages of
AKI [4]. Data on the aetiology, management practices* Correspondence: senaka.ucfm@gmail.com
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distribution, and reproduction in any mediumand outcome in patients admitted to intensive care units
in Sri Lanka has not been studied in depth. The aeti-
ology and patterns of AKI, as well as management prac-
tices are likely to differ in countries with resource
limitations and variations in disease patterns. Tropical
infectious diseases are an important cause of admission
to ICU in Sri Lanka, and certain tropical diseases such
as leptospirosis have a high propensity to cause AKI.
Continuous renal replacement therapy is not routinely
available in many ICUs in Sri Lanka [5].
The Medical Intensive Care Unit of the National
Hospital, Colombo, Sri Lanka, is a dedicated 9 bedded
medical ICU in the largest hospital in Sri Lanka. This
ICU has access to intermittent haemodialysis but has noentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
Figure 1 Flowchart of patients recruited to study.
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unstable patients receive conventional peritoneal dialysis
where required. Admissions are based on priority need,
and are received largely through direct admissions to ICU
from the emergency treatment unit, and from the medical
wards of the hospital. The case-mix is wide, but comprises
only patients primarily with medical problems. Specialist
cover is provided mainly by general internal medicine con-
sultants, with anaesthetic consultants providing input for
vital organ support. The unit is staffed 24 hours by middle
grade (non-specialist, non-training grade) doctors with spe-
cial training in critical care, nurses with critical care train-
ing, physiotherapists and other support staff.
The aims of this study were to: a) to describe the fre-
quency, patterns, aetiological factors, and risk factors,
leading to AKI; b) to determine the relationship between
AKI and outcome; c) to determine the relationship be-
tween the SOFA score and the likelihood of developing
AKI and mortality.
Methods
This was a prospective observational study in the med-
ical intensive care unit (MICU) of the National Hospital,
Colombo, Sri Lanka over a six-month period. We
screened all patients admitted to the MICU for inclusion.
We excluded patients who had chronic kidney disease and
were on renal replacement therapy, and those whose dur-
ation of ICU stay was shorter than 48 hours.
Standard demographic, clinical and physiological data
was obtained prospectively from all the patients.
Demographic information included age, gender and
date of admission. Clinical data included the primary
diagnosis, presence of co-morbidities and the need for
mechanical ventilation. Physiological data included Glas-
gow Coma Scale, arterial oxygen tension (PaO2)/fraction
of inspired oxygen (FiO2) ratio, blood pH, serum so-
dium, potassium, bilirubin, haemoglobin, platelet and
white cell count. Data on kidney function included serum
creatinine, urea and urine output. Severity of illness on
admission and during the ICU stay was assessed using the
SOFA score.
We defined several primary diagnostic categories based
on the primary reason for admission to ICU; classification
into a diagnostic category was based on the diagnosis doc-
umented at the point of admission by the treating clinician.
A diagnosis of sepsis/septic shock was made where the pri-
mary reason for admission was a sepsis related diagnosis
[6], and included sepsis associated with pneumonia, gastro-
intestinal disease, urinary tract infections, central nervous
system infections, soft tissue infections and sepsis of
undetermined source. A cardiac diagnosis was made
where the primary reason for admission was cardiogenic
shock (systolic blood pressure <90 mmHg, absence of
hypovolemia, and clinical signs of poor tissue perfusioni.e., oliguria, cyanosis, cool extremities, altered mentation
[7]), cardiac arrest, congestive cardiac failure (bilateral
basal crackles, cardiomegaly, elevated jugular venous pres-
sure [8]) and acute myocardial infarction (rise in troponin
and either ischaemic chest pain, new ST-T wave changes
or pathological Q waves on ECG [9]). A respiratory diag-
nosis encompassed primary respiratory arrest, aspiration
syndrome, non-cardiogenic pulmonary oedema (not re-
lated to sepsis), exacerbations of chronic obstructive pul-
monary disease or asthma, and pulmonary embolism. A
diagnosis of gastrointestinal haemorrhage included bleed-
ing due to peptic ulcers, diverticulosis and varices. All
other non-surgical gastrointestinal diagnoses were cate-
gorized as ‘other’.
A metabolic/poisoning diagnoses included non-operative
causes of metabolic coma, diabetic ketoacidosis, drug
overdose or other endocrinopathies. Primary neurologic
diagnoses included stroke, intra-cerebral haemorrhage,
subarachnoid haemorrhage, epidural haematoma or other
neurological causes for coma.
Figure 2 Frequency of primary clinical diagnoses of patients.
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abrupt (within 48 hours) reduction in kidney function
(absolute increase in serum creatinine of ≥0.3 mg/dl
(≥26.4 μmol/l), percentage increase in serum creatinine
of ≥50% (1.5-fold from baseline), or reduction in urine
output (documented oliguria of <0.5 ml/kg per hour
for more than six hours)). The 3 stages of AKI were
considered to be: stage 1- increase in serum creatinine
of ≥0.3 mg/dl (≥26.4 μmol/l) or increase to ≥150% to 200%
(1.5-2-fold) from baseline or urine output < 0.5 ml/kg
per hour for >6 hours; stage 2- increase in serumFigure 3 Frequency of AKI in ICU patients.creatinine to >200% to 300% (>2- to 3-fold) from baseline
or urine output <0.5 ml/kg per hour for >12 hours; stage
3- increase in serum creatinine to >300% (>3-fold) from
baseline (or serum creatinine of ≥4.0 mg/dl (≥354 μmol/l)
with an acute increase of at least 0.5 mg/dl (44 μmol/l) or
urine output <0.3 ml/kg per hour for 24 hours or anuria
for 12 hours.
Data was collected using a structured datasheet, adminis-
tered by a research assistant, from the case notes and by
interviewing the patients (or relatives where the patients
were unable to communicate) and treating physicians.
Table 1 Association of AKI with potential risk factors
Risk factor AKI No AKI Total P-value*
Diabetes mellitus
Yes 19 (70.4%) 8 (29.3%) 27 (100%) 0.26
No 46 (56.7%) 35 (53.3%) 81 (100%)
Hypertension
Yes 20 (64.7%) 8 (35.7%) 28 (100%) 0.18
No 45 (56.3%) 35 (44.7%) 80 (100%)
Ischaemic heart disease
Yes 11 (64.7%) 6 (35.7%) 17 (100%) 0.79
No 54 (59.3%) 37 (40.7%) 91 (100%)
Gender
Male 40 (58.8%) 28 (41.1%) 68(100%) 0.83
Female 25 (62.5%) 15 (37.5%) 40 (100%)
Age
≤ 60 years 42 (55.3%) 34 (44.7%) 76 (100%) 0.13
>60 years 23 (71.9%) 9 (29.1%) 32 (100%)
*Fisher’s exact test.
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Categorical data were expressed as proportions and sub-
groups were analyzed using Pearson Chi-square test.
Kaplan-Meier analysis was used to compare length of stay.
Ethics clearance was obtained from the Ethics Re-
view Committee, National Hospital, Colombo on 07th
December 2011 (No AA/ETH/2011). Informed written
consent was obtained from patients, or from the closest
relative where the patient was too ill to communicate. All
investigations that the patients were subjected to were a
part of the routine workup done in any critically ill pa-
tient. No personal information was collected, and indi-
vidual patient data was coded to the bed-head ticket
number. All datasheets were kept in a locked cabinet by
the senior investigators.
Results
A total of 212 patients admitted to the MICU, NHSL
during the study period were screened for inclusion into
the study. Of these, 156 (73.6%) patients satisfied the
inclusion criteria; complete data was available in 108
(69.2%), and these patients were included in the final
analysis (Figure 1). The majority (67, 61.5%) were males.
The mean age was 47.8 years, SD 19.4, range 12-94
years. The mean duration of ICU stay was 11.6 days (SD
10.8, range 2 to 55 days). The majority of patients admit-
ted to ICU, (75.0%) received mechanical ventilation dur-
ing their ICU stay. Sepsis was the commonest primary
diagnosis (45.4%) (Figure 2), with cardiac and respiratory
pathologies accounting for 13.9% and 16.7% of ICU ad-
missions respectively.
During ICU stay, 65 (60.2%) developed acute kidney
injury (AKI). The majority with AKI had AKI stage 3
(38, 58.5%) (Figure 3). Thirty seven (71.1%) of the pa-
tients in AKI stage 3 required dialysis. Among those
who received dialysis, the majority (36, 97.3%) receivedFigure 4 Incidence of AKI in relation to primary diagnosis.intermittent haemodialysis, the remainder receiving peri-
toneal dialysis. Patients with sepsis had a high likelihood
(63.2%) of developing AKI; the highest incidence of AKI
was observed in those with cardiac pathologies as the
primary diagnosis (87%) (Figure 4).
Just under half of the patients (49, 45.4%) had medical
co-morbidities. Of the co-morbidities, hypertension was
the commonest (28, 57.1%), with diabetes and ischae-
mic heart disease present in 27 (55.1%) and 17 (34.7%)
respectively. Age, gender, and the presence of co-
morbid illnesses such as diabetes mellitus, hypertension
or ischaemic heart disease were not associated with de-
veloping AKI (p > 0.05) (Table 1). The duration of ICU
stay was significantly longer among patients with AKI
Figure 5 Kaplan-Meier plot comparing duration of ICU stay among patients with and without AKI on admission.
Wijewickrama et al. BMC Research Notes 2014, 7:305 Page 5 of 7
http://www.biomedcentral.com/1756-0500/7/305compared with no AKI (Kaplan Meier analysis, Mantel-
Cox Log Rank Chi Square: 23.186, p < 0.0001) (Figure 5).
The ICU mortality in the population was 38.9%. Of
those who had AKI only 47.7% were alive on discharge
from the ICU, compared with 76.8% of patients without
AKI (Table 2). There was a statistically significant associ-
ation between the presence of AKI and ICU mortality




AKI absent 8 35 43
AKI present 34 31 65
• Stage 1 13 10 23
• Stage 2 2 2 4
• Stage 3 19 19 38
Total 42 66 108
(Patients with AKI were more likely to die in ICU (Pearson Chi-square:12.369,
p < 0.0001)).
AKI stages: stage 1: increase in serum creatinine of ≥0.3 mg/dl (≥26.4 μmol/l) or
increase to ≥150% to 200% (1.5-2-fold) from baseline or urine output < 0.5 ml/kg
per hour for >6 hours; stage 2: increase in serum creatinine to >200% to 300%
(>2- to 3-fold) from baseline or urine output <0.5 ml/kg per hour for >12 hours;
stage 3: increase in serum creatinine to >300% (>3-fold) from baseline (or serum
creatinine of ≥4.0 mg/dl (≥354 μmol/l) with an acute increase of at least 0.5 mg/dl
(44 μmol/l) or urine output <0.3 ml/kg per hour for 24 hours or anuria for 12 hours.The SOFA score within the first 24 hours of admission
to ICU ranged from 1 to 17. A SOFA score greater than
9 within the first 24 hours of ICU admission was seen in
a total of 49 patients (45.3%). ICU mortality was signifi-
cantly higher among patients with SOFA scores over 9
(Pearson Chi-square 7.581, p = 0.006) (Table 3). Similarly,
AKI was significantly more likely to occur in patients with
SOFA scores greater than 9 (Pearson Chi-square 11.288,
p = 0.001).
Discussion
AKI occurring in ICU is a dangerous complication, irre-
spective of its aetiology. Our findings show a significantly
higher risk of death associated with the development of
AKI. Whether this increased risk of death is due to
complications resulting from AKI per se cannot be de-
termined from this study. Similarly, AKI is associatedTable 3 SOFA scores in relation to the incidence of AKI
and mortality
SOFA score P-value*
= < 9 (n = 59) >9 (n = 49)
AKI (%) 27 (45.7%) 38 (77.5%) 0.001
ICU mortality (%) 16 (27.1%) 26 (53.1%) 0.006
(Both AKI and mortality were higher in patients with SOFA scores over 9).
*Pearson Chi-square.
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cant burden in terms of cost of care. This is of particu-
lar importance in a resource limited setting, as ICU
beds are limited and in great demand. Our findings are
similar to studies in other countries [1,10] and our re-
sults are the first published data on the subject in an
ICU in Sri Lanka. A similar but larger study in Italy
showed that around half the patients admitted to ICU
showed some form of AKI, and 65% of patients in ICU
developed AKI at some stage during their stay, a figure
very close to that seen in our study [10].
The incidence of AKI has increased gradually over the
recent years [11], possibly due to an increase in the use
of aggressive diagnostic and therapeutic interventions
(in particular contrast imaging) [12]. Mortality due to
AKI has shown some evidence of decline over the years,
especially in certain subgroups such as trauma, haemato-
logical malignancy and cardiovascular surgery [1], al-
though it remains one of the most important causes of
death in ICU patients.
As expected, sicker patients were more likely to de-
velop AKI; those with SOFA scores greater than >9 were
more likely to develop AKI, and, as expected, had higher
mortality. Sepsis and cardiovascular causes resulted in a
high incidence of AKI, and older age was also an import-
ant risk factor. In our study we found no correlation be-
tween age, gender or any of the co-morbidities and the
incidence of AKI; in contrast other studies have shown
AKI to be associated with older age, male gender and
cardiovascular disease and hypertension [10]. The reason
for this difference is unclear, but could potentially be
due to the higher incidence of sepsis in our cohort and
the fact that over 75% of our patients belonged to a
younger age group.
No specific preventive strategies are available for AKI
apart from adequate fluid resuscitation and avoidance of
nephrotoxic agents, in particular intravenous contrast
[13,14]. Inotropic support to augment blood pressure is
of benefit, and noradrenaline is the preferred agent; low
dose dopamine is no longer thought to be useful [6].
Other agents which showed promise in the past, such as
tight glycaemic control, corticosteroids, and activated
protein C, have failed to show therapeutic benefit in pre-
venting AKI or improving mortality [6]. Dialysis is cer-
tainly beneficial, although the exact dose of dialysis
remains controversial [15]. While overall there is no evi-
dence that continuous renal replacement therapy is super-
ior to conventional haemodialysis, most studies evaluating
this have excluded patients who are haemodynamically
too unstable to tolerate conventional haemodialysis [16].
The ICU where this study was performed does not have
routine access to continuous renal replacement, thus most
patients are managed with intermittent haemodialysis;
this makes management of AKI in the setting of shockdifficult. Peritoneal dialysis is sometimes used in such situ-
ations, although evidence suggests that it is inferior to
haemodialysis [17]. Haemodialysis is costly, and is a sig-
nificant burden on the healthcare system, especially in de-
veloping countries.
Conclusions
The incidence of AKI is high in patients admitted to
ICU, and the development of AKI is associated with
poor outcome and reduced survival. AKI significantly in-
creases the duration of ICU stay, and this is likely to add
to the healthcare burden. Age, gender or the presence of
comorbidities do not appear to influence the incidence
of AKI in our ICU patients. However sicker patients, with
higher SOFA scores, are more likely to develop AKI, and
are less likely to survive.
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